英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Cowlike查看　Cowlike　在百度字典中的解释百度英翻中〔查看〕
Cowlike查看　Cowlike　在Google字典中的解释Google英翻中〔查看〕
Cowlike查看　Cowlike　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Support | ONGENTYS® (opicapone) capsules
    Support Personalized patient support services Prescribe ONGENTYS ® (opicapone) capsules with confidence for patients with Parkinson's disease experiencing "off" episodes ONGENTYS is widely available through any patient-preferred retail pharmacy, including convenient mail order options
  • ONGENTYS® (opicapone) capsules | Savings and Support
    ONGENTYS ® (opicapone) capsules is a prescription medicine used with levodopa and carbidopa in people with Parkinson's disease (PD) who are having "OFF" episodes
  • Helping Patients and Communities Access our Medicines | Amneal
    Get in touch with Amneal Access customer service, report adverse events, and find support for our generic, biosimilar, injectable and specialty portfolios
  • Ongentys (Opicapone) for Parkinsons Disease | MyParkinsonsTeam
    Ongentys is a member of a class of drugs called catechol-O-methyltransferase (COMT) inhibitors Ongentys is believed to work by preventing the body from breaking down levodopa This helps more levodopa enter the brain and turn into dopamine, which protects against symptoms of Parkinson’s How do I take it?
  • Ongentys Patient Assistance Program (PAP) for Parkinson’s . . .
    Lower Ongentys prescription expenses to $80 month through the PAP Helps patients control Parkinson’s symptoms alongside standard therapies
  • Ongentys: Uses, Side Effects, Warnings - Drugs. com
    Ongentys (opicapone) is used to treat Parkinson’s disease patients experiencing “off” episodes Includes Ongentys side effects, interactions and indications
  • Ongentys (opicapone) Approved for “Off” Episodes in Parkinson . . .
    The U S FDA has approved Ongentys (opicapone) for people with Parkinson’s disease who have “off” episodes while taking a medicine called carbidopa levodopa
  • 026 Opicapone for the Treatment of Early Wearing-Off in . . .
    Background Levodopa (L-dopa) is the most effective therapy for the symptomatic treatment of Parkinson’s disease (PD); however, its therapeutic effect decreases with the progression of PD, leading to wearing-off symptoms1,2
  • Parkinsons Disease - Ongentys
    Guidelines The International Parkinson and Movement Disorder Society published an evidence-based review for treatment of motor symptoms of Parkinson’s disease (2018); an update specific to motor fluctuations was published in 2025 2,3 In the 2025 update, Ongentys is noted to be efficacious in the treatment of motor fluctuations
  • label - accessdata. fda. gov
    The efficacy of ONGENTYS for the adjunctive treatment to levodopa carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes was evaluated in two double-blind, randomized, parallel-group, placebo- and active-controlled (Study 1, NCT01568073), or placebo-controlled (Study 2, NCT01227655) studies of 14-15 week duration





中文字典-英文字典  2005-2009